InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,453.55
(
0.40%
)
US TECH 100
19,240.40
(
0.38%
)
Dow Jones
38,663.26
(
0.19%
)
Brent Oil
83.25
(
1.36%
)
Bitcoin
65,612.26
(
-1.54%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ADVFN_franknstein

Send PM Follow Ignore
Followers 27
Posts 3592
Boards Moderated 0
Alias Born 08/16/2013

ADVFN_franknstein

Re: gotinearly post# 156176

Monday, 01/09/2017 9:48:54 AM

Monday, January 09, 2017 9:48:54 AM

Post# of 158400
Not forgotten. Posted it just last week on RGBP board.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=127642458


Regen
As of December 13, 2016 Bio-Matrix Scientific Group, Inc owns 29,076,665 Common Shares of Regen, 2,907,666 shares of Regen’s Series A Preferred Stock, 30,000 shares of Regen’s Series AA Preferred Stock representing 11.1% of our outstanding share capital and 56.65% of the voting power as of December 13, 2016.


Entest
As of November 15, 2016 Bio-Matrix Scientific Group Inc. owned 66,667 common shares of the Company .
As of November 15, 2016 Regen Biopharma owns 8,000,000 common shares of the Company
Entest Biomedical Inc. is under common control with Bio Matrix Scientific Group.


Not that much and decreasing with every quarter.
But what is leftover will probably enable the step up to 0.0003.

The public easily confuses him who fishes in troubled waters with him who draws up water from the depths.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up